Cargando…
Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track?
Uzbekistan has a large burden of drug-resistant tuberculosis (TB). To deal with this public health threat, the National TB Program introduced rapid molecular diagnostic tests such as Xpert MTB/RIF (Xpert) and line probe assays (LPAs) for first-line and second-line drugs. We documented the scale-up o...
Autores principales: | Yuldashev, Sharofiddin, Parpieva, Nargiza, Alimov, Salikhdjan, Turaev, Laziz, Safaev, Khasan, Dumchev, Kostyantyn, Gadoev, Jamshid, Korotych, Oleksandr, Harries, Anthony D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124440/ https://www.ncbi.nlm.nih.gov/pubmed/33924862 http://dx.doi.org/10.3390/ijerph18094685 |
Ejemplares similares
-
Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–2018
por: Safaev, Khasan, et al.
Publicado: (2021) -
Treatment Outcomes of Isoniazid-Resistant (Rifampicin Susceptible) Tuberculosis Patients in Uzbekistan, 2017–2018
por: Sayfutdinov, Zayniddin, et al.
Publicado: (2021) -
Treatment Compliance of Multidrug Resistant Tuberculosis in Uzbekistan: Does Practice Follow Policy?
por: Usmanova, Ruzilya, et al.
Publicado: (2021) -
Operational Research to Inform Programmatic Approaches to the Management of Tuberculosis in Uzbekistan
por: Gadoev, Jamshid, et al.
Publicado: (2021) -
Hospitalizations and Treatment Outcomes in Patients with Urogenital Tuberculosis in Tashkent, Uzbekistan, 2016–2018
por: Ismatov, Bakhtiyor, et al.
Publicado: (2021)